CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-19 | Bolzon Bradley J PhD Director | Other acquisition | +2,378 | 81,452 | ||
| 2021-02-19 | Bolzon Bradley J PhD Director | Other disposition | −12,189 | 26,583 | ||
| 2021-02-19 | Bolzon Bradley J PhD Director | Other acquisition | +2,633 | 84,085 | ||
| 2021-02-19 | Bolzon Bradley J PhD Director | Other disposition | −84,085 | 0 | ||
| 2021-02-19 | Bolzon Bradley J PhD Director | Other acquisition | +18,973 | 46,689 | ||
| 2021-02-19 | Bolzon Bradley J PhD Director | Other disposition | −27,861 | 62,869 | ||
| 2021-02-19 | Bolzon Bradley J PhD Director | Other acquisition | +6,018 | 6,018 | ||
| 2021-02-19 | Bolzon Bradley J PhD Director | Other disposition | −6,018 | 0 | ||
| 2021-02-19 | Bolzon Bradley J PhD Director | Other acquisition | +847 | 47,536 | ||
| 2021-01-19 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +27,500 | $51.49 | $1.4M | 49,931 |
| 2021-01-19 | KASINGER JAMES R. General Counsel and Secretary | Sale | −6,785 | $203.58 | $1.4M | 43,146 |
| 2021-01-19 | KASINGER JAMES R. General Counsel and Secretary | Sale | −7,818 | $204.40 | $1.6M | 35,328 |
| 2021-01-19 | KASINGER JAMES R. General Counsel and Secretary | Sale | −8,997 | $205.60 | $1.8M | 26,331 |
| 2021-01-19 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,800 | $206.05 | $371K | 24,531 |
| 2021-01-19 | KASINGER JAMES R. General Counsel and Secretary | Sale | −2,100 | $207.61 | $436K | 22,431 |
| 2021-01-19 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Stock Option (right to buy) | −27,500 | 12,500 | ||
| 2021-01-15 | Klein Lawrence Otto CBO & COO | Option exercise | +16,334 | $14.43 | $236K | 26,942 |
| 2021-01-15 | Kulkarni Samarth Chief Executive Officer | Option exercise | +20,000 | $1.81 | $36K | 202,989 |
| 2021-01-15 | Kulkarni Samarth Chief Executive Officer | Sale | −3,140 | $211.83 | $665K | 199,849 |
| 2021-01-15 | Kulkarni Samarth Chief Executive Officer | Sale | −6,525 | $212.75 | $1.4M | 193,324 |
Page 33 of 46 · 910 trades